These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Self-management of psychiatric symptoms using over-the-counter (OTC) psychopharmacology: the S-DTM therapeutic model--Self-diagnosis, self-treatment, self-monitoring. Charlton BG Med Hypotheses; 2005; 65(5):823-8. PubMed ID: 16111835 [TBL] [Abstract][Full Text] [Related]
23. Paradoxes of US psychopharmacology practice in 2013: undertreatment of severe mental illness and overtreatment of minor psychiatric problems. de Leon J J Clin Psychopharmacol; 2014 Oct; 34(5):545-8. PubMed ID: 24781438 [No Abstract] [Full Text] [Related]
24. Psychopharmacogenetics and psychiatric genetics: similar methodological challenges. Maziade M; Roy MA; Mérette C; Bissonnette L; Quirion R; Palmour R J Psychiatry Neurosci; 1999 May; 24(3):211-4. PubMed ID: 10354654 [No Abstract] [Full Text] [Related]
25. [Clinicotoxicological analysis, especially in psychiatry]. Allgén LG Nord Med; 1966 Apr; 75(14):392-4. PubMed ID: 5948740 [No Abstract] [Full Text] [Related]
26. New directions in clinical psychopharmacology. Cardoni AA Conn Med; 1997 Sep; 61(9):587-95. PubMed ID: 9334514 [TBL] [Abstract][Full Text] [Related]
27. International perspectives of psychopharmacology: the interface of research and treatment. Klerman GL Psychopharmacol Bull; 1979 Jul; 15(3):51-3. PubMed ID: 493465 [No Abstract] [Full Text] [Related]
28. Questions and answers for the advanced practice psychiatric nurse. Antai-Otong D Perspect Psychiatr Care; 2003; 39(1):33-4. PubMed ID: 12724964 [TBL] [Abstract][Full Text] [Related]
29. Target-symptom psychopharmacology: between the forest and the trees. Bostic JQ; Rho Y Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):289-302. PubMed ID: 16321735 [TBL] [Abstract][Full Text] [Related]
30. [Problems concerning a psychopharmacological community examination]. Eckmann F; Immich H; Neumann H; Schäpperle O; Tempel H Med Klin; 1965 Oct; 60(42):1697-700. PubMed ID: 5867183 [No Abstract] [Full Text] [Related]
31. Drugs and psychiatric readaptation. Bayülkem F Isr Ann Psychiatr Relat Discip; 1973 Jun; 11(2):108-11. PubMed ID: 4518326 [No Abstract] [Full Text] [Related]
32. The psychologist's role in the collaborative process of psychopharmacology. Weene KA J Clin Psychol; 2002 Jun; 58(6):617-21. PubMed ID: 12007153 [TBL] [Abstract][Full Text] [Related]
33. Office management of patients with emotional disorders. Goldman D Psychosomatics; 1965; 6(5):365-70. PubMed ID: 5832605 [No Abstract] [Full Text] [Related]
34. [Psychopharmacologic agents from the viewpoint of the psychiatric clinic. Effect, indication, significance and danger]. Lange E; Scholz V Pharmazie; 1966 Mar; 21(3):57-64. PubMed ID: 4863580 [No Abstract] [Full Text] [Related]
35. Myths and facts in contemporary psychopharmacotherapy: evidence-based vs. evidence-biased treatment algorithms practice. Jakovljević M Psychiatr Danub; 2007 Dec; 19(4):342-9. PubMed ID: 18000486 [TBL] [Abstract][Full Text] [Related]
36. [Ataractic treatment in psychiatry and general practice. Drug preparations review, 7]. Hertrich O Fortschr Med; 1983 Aug; 101(30):1374-6. PubMed ID: 6618398 [No Abstract] [Full Text] [Related]
37. Psychiatric illness in family practice. Hesbacher PT; Rickels K; Morris RJ; Newman H; Rosenfeld H J Clin Psychiatry; 1980 Jan; 41(1):6-10. PubMed ID: 7351399 [TBL] [Abstract][Full Text] [Related]
38. The collection, storage and retrieval of clinical psychopharmacological data. Teller DN; Denber HC Dis Nerv Syst; 1969 Feb; 30(2):Suppl:60-4. PubMed ID: 5775319 [No Abstract] [Full Text] [Related]